 
							Acasti Pharma, Inc. (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.
 
							Acasti Pharma, Inc. (ACST) relating to its proposed merger with Grace Therapeutics, Inc. ACST shareholders are expected to own approximately 55% of the combined company.